Advancing
Care for All

Lupin’s journey is a testament to the potential of human imagination, compassion, and the unwavering pursuit of a better tomorrow.

Know More
People. Performance. Possibilities. Driven by Purpose. - Investor RelationsPeople. Performance. Possibilities. Driven by Purpose. - Investor Relations

Integrated Report 2024–2025

Know More
Sustainability - World No. 1 in pharmaceutical industrySustainability - World No. 1 in pharmaceutical industry

With S&P Global ESG Score of 91, we are
World No. 1

in sustainability in the pharmaceutical industry*Score as on February 7, 2026

Know More
Founder

The Lupin Story

Driven by Science,
Inspired by Patients

Founded by Dr. Desh Bandhu Gupta in 1968,
Lupin aimed to improve access to essential
medicines. Today we stand tall as a globally
trusted pharmaceutical company guided by
science, quality, and a patient-first mindset.

Know More

Our Purpose

We Catalyze
Treatments
That Transform
Hope Into
Healing

Ours is a purpose-driven
journey of over 5 decades,
where we aim to improve
lives, build sustainability
and deliver long-term
solutions to all.

Relief from disease

Delivering meaningful
treatments for today and
tomorrow

Know More

Innovation to unlock access at scale

Making complex, cutting-edge
healthcare solutions accessible
to all

Know More

Solutions for underserved communities

Serving markets and patients
overlooked by others

Know More

Overview

Global Impact
Human Touch

0+

Global Facilities

Know More
0+

Countries

Know More
0+

Employees

Know More
0+

Products

Know More

Our Business

Lupin operates a highly diversified pharmaceutical business with a
strong presence across key global markets. Our operations span
generics, complex formulations,
branded products, and other
high-burden specialty segments, supported by robust R&D
and manufacturing capabilities.
Spread across developed and emerging markets, Lupin's business is anchored in patient-centric approach and operational excellence.

Know More
Healthcare Professional with Patient
Professional Woman

Investors

Stock

Quotes

Last updated on —

NSE :

BSE :

Performance

Lupin Q1 FY26

Financial Results

Earnings Release

View

Analyst Presentation

View

Exchange Releases

Lupin Financial Results

for the quarter

June 30, 2025

View Investor Reports
Sustainability

Sustainability

Caring for People,

Planet, Patients

Our mission extends beyond medicines. We invest
in people, communities, and a greener tomorrow.

Know More
CSR Activities

Community

Beyond

Medicines

Lupin Foundation works in 5,400+ villages in 8 states of India.

At the core of Lupin's community work is a passion
to build sustainable models for uplifting lives.

Know More
Life at Lupin

Life

at Lupin

Our people are the driving force behind our mission to improve patients’ lives and longevity.

Join Our Team

News and Insights

29 December, 2025

Lupin Signs Exclusive Licensing Agreement with Gan & Lee Pharmaceuticals for novel GLP-1 receptor agonist

18 December, 2025

Lupin Signs Exclusive Licensing Agreement with Neopharmed for Gastroenterology Brand Plasil® in the Philippines and Brazil

Product Finder
Leading Global Pharmaceutical Company in India - Lupin